marec 13, 2026 0 0 CELEX:62024CO0566: Ordonnance de la Cour (septième chambre) du 5 mars 2026.#Consumer Rights Recovery sp. z o.o. contre Santander Bank Polska S.A.#Renvoi préjudiciel – Article 53, paragraphe 2, et article 100, paragraphe 2, du règlement de procédure de la Cour – Litige au principal devenu sans objet – Non-lieu à statuer.#Affaire C-566/24. This document does not exist in English.
julij 23, 2026 0 0 CELEX:62024CO0566_INF: Order of the Court (Seventh Chamber) of 5 March 2026.#Consumer Rights Recovery sp. z o.o., anciennement Helpfind Recovery sp. z o.o. v Santander Bank Polska S.A.#Request for a preliminary ruling from the Sąd Rejonowy dla Łodzi-Śródmieścia w Łodzi.#Case C-566/24.
januar 16, 2025 0 0 CELEX:62024CO0577: Order of the Court of 8 January 2025.#Peikko Group Oy v European Union Intellectual Property Office.#Appeal – EU trade mark – Determination as to whether appeals should be allowed to proceed – Article 170b of the Rules of Procedure of the Court of Justice – Request not demonstrating that an issue is significant with respect to the unity, consistency or development of EU law – Appeal not allowed to proceed.#Case C-577/24 P.
julij 04, 2025 0 0 CELEX:62024CO0577_INF: Order of the Court of 8 January 2025.#Peikko Group Oy v European Union Intellectual Property Office.#Appeal – EU trade mark – Determination as to whether appeals should be allowed to proceed – Article 170b of the Rules of Procedure of the Court of Justice – Request not demonstrating that an issue is significant with respect to the unity, consistency or development of EU law – Appeal not allowed to proceed.#Case C-577/24 P.
februar 14, 2025 0 0 CELEX:62024CO0578: Beschluss des Gerichtshofs vom 3. Februar 2025.#Sophienwald AG gegen Amt der Europäischen Union für geistiges Eigentum.#Rechtsmittel – Unionsmarke – Zulassung von Rechtsmitteln – Art. 170b der Verfahrensordnung des Gerichtshofs – Antrag, in dem die Bedeutsamkeit einer Frage für die Einheit, die Kohärenz oder die Entwicklung des Unionsrechts nicht dargetan wird – Nichtzulassung des Rechtsmittels.#Rechtssache C-578/24 P. This document does not exist in English.
julij 07, 2025 0 38 CELEX:62024CO0578_INF: Order of the Court of 3 February 2025.#Sophienwald AG v European Union Intellectual Property Office.#Case C-578/24 P.
marec 24, 2025 0 0 CELEX:62024CO0586: Ordonnance de la Cour (neuvième chambre) du 3 mars 2025.#I.G. et D.L.#Renvoi préjudiciel – Article 53, paragraphe 2, du règlement de procédure de la Cour – Article 267 TFUE – Notion de “juridiction” – Juge de la chambre civile du Sąd Najwyższy (Cour suprême, Pologne) – Juge nommé par le président de la République de Pologne sur la base d’une résolution émanant de la Krajowa Rada Sądownictwa (Conseil national de la magistrature, Pologne) dans sa nouvelle composition – Renvoi préjudiciel émanant d’une formation de jugement n’ayant pas la qualité de tribunal indépendant et impartial, établi préalablement par la loi – Irrecevabilité manifeste.#Affaire C-586/24. This document does not exist in English.
september 15, 2025 0 15 CELEX:62024CO0586_INF: Order of the Court (Ninth Chamber) of 3 March 2025.#I.G. and D.L.#Requests for a preliminary ruling from the Sąd Najwyższy.#Joined Cases C-586/24 and C-605/24.
oktober 12, 2024 0 0 CELEX:62024CO0599: Order of the Vice-President of the Court of 4 October 2024.#Accord Healthcare, SL v European Commission.#Appeal – Intervention – Public health – Medicinal product for human use – Decision granting marketing authorisation for the medicinal product Degarelix Accord – Action for annulment – Time limits – Force majeure or unforeseeable circumstances – Dismissal.#Case C-599/24 P(I).
januar 25, 2025 0 0 CELEX:62024CO0599_INF: Order of the Vice-President of the Court of 4 October 2024.#Accord Healthcare, SL v European Commission.#Appeal – Intervention – Public health – Medicinal product for human use – Decision granting marketing authorisation for the medicinal product Degarelix Accord – Action for annulment – Time limits – Force majeure or unforeseeable circumstances – Dismissal.#Case C-599/24 P(I).